feedback

Provider Statement

This continuing medical education activity is provided by .

Support Statement

This activity is supported by educational grants from Bristol-Myers Squibb, Lilly, and Pfizer.

Activity Chair

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of
Case Western Reserve University
Director of the R.J. Fasenmyer Center for
Clinical Immunology
Cleveland Clinic
Cleveland, OH

Faculty

Jonathan Kay, MD
Timothy S. and Elaine L. Peterson Chair in Rheumatology
Professor of Medicine
University of Massachusetts Medical School
University of Massachusetts Memorial Medical Center
Worcester, MA


John Tesser, MD
Clinical Lecturer, University of Arizona Health Sciences Center
Adjunct Clinical Professor, Midwestern University College of Health Sciences
Arizona Arthritis & Rheumatology Associates, P.C.
Phoenix, AZ


Reviewers

Kevin D. Deane, MD, PhD
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP

Activity Details

Credit Type: CME
Credit Amount: 0.25 AMA PRA Category 1 Credit
Release Date: September 6, 2016
Expiration Date: September 5, 2017
Estimated Time to Complete Activity: 15 minutes
Registration Required: Yes
Fee for Activity: There is no fee for participating in this activity.

Target Audience

The intended audience for this activity is rheumatologists, rheumatology nurses, and other health care professionals involved in the treatment of patients with rheumatoid arthritis (RA).

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to examine the immunopathogenesis and therapeutic landscape of RA and allied conditions, as well as strategies to mitigate risk from biologic and immune-based agents.

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, September 6, 2016 to September 5, 2017.

How to Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must complete the pretest, review the CME content, and complete the CME posttest and the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

Steering Committee and Faculty report the following relationship(s): 
Leonard H. Calabrese, DO 
Consulting Fee: GlaxoSmithKline, Janssen, Pfizer, Sanofi 
Speakers Bureau: AbbVie, Bristol-Myers Squibb, Crescendo, Genentech, Janssen

Joseph E. Craft, MD 
Non-CME Services Fees: Bristol-Myers Squibb, MedImmune

John J. Cush, MD 
Consulting Fee: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Janssen, Lilly, Novartis, Pfizer, UCB
Clinical Investigator: AbbVie, AstraZeneca, Celgene, Janssen, Novartis, Pfizer

Allan Gibofsky, MD, JD, MACR, FACP, FCLM 
Consulting Fee: AbbVie, Celgene, Iroko Pharmaceuticals, Pfizer, Takeda 
Speakers Bureau: AbbVie, Celgene, Iroko Pharmaceuticals, Pfizer
Ownership Interest: AbbVie, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, Regeneron

Jonathan Kay, MD 
Consulting Fee: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim GMbH, Bristol-Myers Squibb, Elil-Lilly, Epirus Biopharmaceuticals, Genentech Inc., GlaxoSmithKline, Hospira, Janssen, Merck, Myriad, Novartis, Roche, Pfizer, Samsung Bioepis, Sandoz, UCB
Contract Research: (Paid to Institution) AbbVie, Genentech, Eli-Lilly, Pfizer, Roche

Elizabeth Kirchner, CNP, MSN 
Consulting Fee: Pfizer, Sanofi 
Speakers Bureau: Crescendo Bioscience

William F.C. Rigby, MD
Consulting Fee: Bristol-Myers Squibb, Lilly, Pfizer, Roche
Non-CME Services Fees: Bristol-Myers Squibb
Contracted Research: Amgen, Bristol-Myers Squibb, Pfizer, Roche

Sergio Schwartzman, MD
Consulting Fee: AbbVie, Crescendo, Epirus, Genentech, Hospira, Janssen, Novartis, Pfizer, Regeneron
Speakers Bureau: AbbVie, Crescendo, Genentech, Hospira, Janssen, Novartis, Pfizer
Ownership Interest: Amgen, Gilead, Medtronic, Pfizer
Board Member: Discus-Analytics National Psoriasis Foundation
Scientific Advisory Board Member: Bioscience, Crescendo

Gregg Silverman, MD
Consulting Fee: Bristol-Myers Squibb, Genentech 
Speakers Bureau: Genentech

John Tesser, MD 
Consulting Fee: Bristol-Myers Squibb, Lilly, Pfizer 
Speakers Bureau: Bristol-Myers Squibb, Pfizer 
Contracted Research: Bristol-Myers Squibb, Lilly, Pfizer

Reviewers report the following relationship(s):
Kevin Deane, MD, PhD
Consulting Fee: Janssen 
Honoraria: Medscape

Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP 
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.